RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Incidence of medication problems and their harm potential following hospital discharge among pediatric patients with epilepsy were not significantly different for individuals who received discharge ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of all teens with a history of cardiac surgery still used more than one medication. Clinicians must ...
Perampanel was found effective and safe for prolonged use in children with epilepsy, according to one study. After its 2012 approval as an antiseizure medication, perampanel (Fycompa) has been found ...
A recent report from the US Pharmacopeia (USP) reveals that drug shortages decreased by 23% in 2025; however, the duration of ...
In addition to healthy weight reduction through lifestyle changes, experts recommend anti-obesity medications and bariatric surgery to help manage metabolic dysfunction–associated steatotic liver ...
Please provide your email address to receive an email when new articles are posted on . From 2009 to 2020, emergency department visits for unsupervised pediatric medication exposures decreased by ...
Hope is on the horizon for sick children requiring intravenous canulation to administer medication. A Griffith University–led randomized controlled trial has provided evidence about the most effective ...
According to the USP report, the duration of drug shortages increased to 5.3 years in 2025. This is a result of new shortages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results